bpc-157 news 2026 This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make Peptide news worth paying attention

Hims, a telehealth company that sells direct-to-consumer finasteride and GLP-1s, has signaled that it will move to sell the controversial substances should they be approved after acquiring a peptide manufacturing facility in 2025

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision

Recalls & Warnings July 12, 2013 Herbal Supplement Company Warned For Drug Claims, Manufacturing Violations On June 18, 2013, the FDA issued a warning letter to Herbs of Light, Inc

Add methylmalonic acid if your result comes back borderline

Results will be noticeably compromised

they are the subject of intense interest across drug discovery, regenerative medicine, anti-aging, obesity, and metabolic research, but they are also delicate, hygroscopic, and easily denatured